Effects of Telerehabilitation-Based Motor Imagery Training on Pain in People With Multiple Sclerosis
Launched by DOKUZ EYLUL UNIVERSITY · Apr 9, 2022
Trial Information
Current as of June 25, 2025
Completed
Keywords
ClinConnect Summary
Multiple sclerosis (MS) is a chronic, progressive, and demyelinating disease of the central nervous system that affects more than 2.5 million people worldwide and is more common in young adults. The most common clinical signs and symptoms include motor dysfunction, fatigue, spasticity, cognitive impairment, depression, decreased quality of life, bladder and bowel dysfunction and pain. People with Multiple Sclerosis (pwMS) show a wide range of pain symptoms, from acute pain symptoms to chronic pain symptoms. Pain is an important symptom in pwMS and is often associated with disability. Pain i...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Having been diagnosed with MS according to McDonald diagnostic criteria
- • Not having an attack in the last 3 months.
- • To have sufficient smartphone/tablet or computer knowledge to participate in the study or to have a relative who can help in this regard.
- • Having an active internet connection at home.
- • Having a smart phone/tablet or computer suitable for videoconferencing.
- • Having a smartphone or tablet.
- • Having a pain level of at least 30 mm on the 100 mm visual analog scale (VAS) for at least 3 months in at least one of the hand/wrist, foot/ankle, knee, shoulder, neck and back regions.
- • No change in medications used for pain in the last 2 months.
- • Not receiving additional treatment other than routine treatments.
- • To be able to read and understand Turkish.
- Exclusion Criteria:
- • Pregnancy
- • Having a musculoskeletal, cardiovascular, pulmonary, metabolic, or other disease severe enough to preclude participation in the study.
- • Presence of conditions other than MS that can cause pain, such as cancer, diabetes, overt osteoarthritis, or rheumatoid arthritis based on laboratory or imaging findings
- • Having a psychiatric illness.
- • Presence of severe cognitive impairment detected by the physician at a level that prevents the tests from being performed
- • Having severe vision and hearing problems.
About Dokuz Eylul University
Dokuz Eylul University is a prominent educational institution located in İzmir, Turkey, recognized for its commitment to advancing medical research and clinical innovation. As a clinical trial sponsor, the university leverages its extensive academic resources and expertise to conduct cutting-edge research aimed at improving patient outcomes. With a focus on interdisciplinary collaboration and adherence to ethical standards, Dokuz Eylul University strives to contribute valuable insights to the medical community while fostering the development of new therapeutic interventions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Izmir, , Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials